NeuroSense Therapeutics (NRSN) null Earnings

31AugConfirmed
Q2 2021
Dec 21
Apr 22
Aug 22
-0.3
-0.27
-0.24
-0.21

Details

Expected EPS
-0.28
Actual EPS
-0.3
Surprise EPS
-0.02
Surprise Percent
+7.14%

Description

NeuroSense Therapeutics (NRSN) has reported earnings of -0.3 per share for .

0 Comments

Share your thoughts